Brain Aneurysm Foundation

Funding Research Today to Prevent Ruptures Tomorrow

Through BAF support, researchers studying new diagnostic strategies designed to expand screening and improve understanding of brain aneurysm risk—before ruptures occur.

 

Pause video
University of Louisville Research Foundation, Inc.

This project’s goal is to determine how cigarette smoking, vaping, and newer “tobacco-free” nicotine products can affect the development and rupture of brain aneurysms. By combining a novel inhalation ‘smoking’ model with the established mouse aneurysm formation model, we hope to understand how these products can damage blood vessels and increase aneurysm risk.

We hope our findings will provide the first-ever biological data on how vaping and synthetic nicotine products influence brain aneurysm formation and rupture. These results could help guide public health recommendations and policies, inform patients and healthcare providers about potential risks, and lay the foundation for future therapies and prevention strategies that reduce aneurysm-related strokes and deaths.

The Facts

  • Large group of serious people.
    facts-icon-people

    1 in 50 people in the U.S. has an unruptured brain aneurysm

  • Fact_18mins_serious
    facts-icon-ambulance

    A brain aneurysm ruptures every 18 minutes

  • detection_homepage
    Brain icon

    Early detection is critical as most brain aneurysms are treatable 

  • Fact_Federal_funding
    facts-icon-calculator

    The federal government spends only $3.02 per year on brain aneurysm research for each person afflicted

Personal Stories

Our Impact

The Brain Aneurysm Foundation is the leading advocacy organization supporting education, research, and policy to transform the treatment of brain aneurysms. Funds raised are used for disease awareness efforts and grants that provide support to academic researchers studying the underlying biology of aneurysms or developing new treatment methods. Grantees include leading academic researchers whose work includes efforts to develop biomarkers to better predict and develop potential therapeutics for aneurysms, understand the impact of genetics on rupture outcomes, and create new device technology, drug delivery and robotic approaches to evolve treatment. The BAF has committed nearly $6 million to fund dozens of research efforts in the U.S. and Canada.

Take Action

Support Groups

A critical resource for the recovery journey of patients and families.
Join Us

Partners

Follow Us

@bafound Follow Us